Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1979 Oct;131(4):277–284.

Mannitol

Allen R Nissenson 1, Raymond E Weston 1, Charles R Kleeman 1
PMCID: PMC1271822  PMID: 388867

Abstract

Mannitol may be useful clinically both as a diuretic and as an obligate extracellular solute. As a diuretic it can be used to treat patients with intractable edema states, to increase urine flow and flush out debris from the renal tubules in patients with acute tubular necrosis, and to increase toxin excretion in patients with barbiturate, salicylate or bromide intoxication. As an obligate extracellular solute it may be useful to ameliorate symptoms of the dialysis disequilibrium syndrome, to decrease cerebral edema following trauma or cerebrovascular accident, and to prevent cell swelling related to renal ischemia following cross-clamping of the aorta. Largely unexplored uses for mannitol include its use as an osmotic agent in place of dextrose in peritoneal dialysis solutions, its use to maintain urine output in patients newly begun on hemodialysis, and its use to limit infarct size following acute myocardial infarction.

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS R. E., KIRSCHNER R. J., LEOPOLD I. H. Ocular hypotensive effect of intravenously administered mannitol; a preliminary report. Arch Ophthalmol. 1963 Jan;69:55–58. doi: 10.1001/archopht.1963.00960040061012. [DOI] [PubMed] [Google Scholar]
  2. Adamson J. S., Jr, Flanigan W. J., Ackerman G. L. Treatment of bromide intoxication with ethacrynic acid and mannitol diuresis. Ann Intern Med. 1966 Oct;65(4):749–752. doi: 10.7326/0003-4819-65-4-749. [DOI] [PubMed] [Google Scholar]
  3. Ames A., 3rd, Wright R. L., Kowada M., Thurston J. M., Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol. 1968 Feb;52(2):437–453. [PMC free article] [PubMed] [Google Scholar]
  4. Anderson C. F., O'Kane H. O., Shorter R. G., Johnson W. J., Hallenbeck G. A. Use of diuretic agents during oliguria after renal transplantation. Surgery. 1970 Feb;67(2):249–254. [PubMed] [Google Scholar]
  5. Atkins J. M., Wildenthal K., Horwitz L. D. Cardiovascular responses to hyperosmotic mannitol in anesthetized and conscious dogs. Am J Physiol. 1973 Jul;225(1):132–137. doi: 10.1152/ajplegacy.1973.225.1.132. [DOI] [PubMed] [Google Scholar]
  6. Aviram A., Pfau A., Czaczkes J. W., Ullmann T. D. Hyperosmolality with hyponatremia, caused by inappropriate administration of mannitol. Am J Med. 1967 Apr;42(4):648–650. doi: 10.1016/0002-9343(67)90066-6. [DOI] [PubMed] [Google Scholar]
  7. BARRY K. G., BERMAN A. R. Mannitol infusion. III. The acute effect of the intravenous infusion of mannitol on blood and plasma volumes. N Engl J Med. 1961 May 25;264:1085–1088. doi: 10.1056/NEJM196105252642105. [DOI] [PubMed] [Google Scholar]
  8. BARRY K. G., COHEN A., LEBLANC P. Mannitolization. I. The prevention and therapy of oliguria associated with cross-clamping of the abdominal aorta. Surgery. 1961 Aug;50:335–340. [PubMed] [Google Scholar]
  9. BARRY K. G., HUNTER R. H., DAVIS T. E., CROSBY W. H. Acute uric acid nephropathy. Treatment with mannitol diuresis and peritoneal dialysis. Arch Intern Med. 1963 Apr;111:452–459. doi: 10.1001/archinte.1963.03620280052008. [DOI] [PubMed] [Google Scholar]
  10. BERNSTEIN L. M., GROSSMAN A. Diuretic effect of mannitol in nephrotic edema. J Lab Clin Med. 1962 Feb;59:309–319. [PubMed] [Google Scholar]
  11. Bouzarth W. F., Goldfedder P., Shenkin H. A. Hypertonic mannitol as a treatment for complications of cerebral arteriography. Am J Roentgenol Radium Ther Nucl Med. 1968 Sep;104(1):119–122. doi: 10.2214/ajr.104.1.119. [DOI] [PubMed] [Google Scholar]
  12. Brachfeld N., Christodoulou J., Keller N., Smithen C. Hemodynamic, metabolic, and ultrastructural consequences of hyperosmolal mannitol after myocardial anoxia. Recent Adv Stud Cardiac Struct Metab. 1975;7:459–466. [PubMed] [Google Scholar]
  13. Brachfeld N. Metabolic evaluation of agents designed to protect the ischemic myocardium and to reduce infarct size. Am J Cardiol. 1976 Mar 31;37(4):528–532. doi: 10.1016/0002-9149(76)90392-1. [DOI] [PubMed] [Google Scholar]
  14. Bullock W. E., Luke R. G., Nuttall C. E., Bhathena D. Can mannitol reduce amphotericin B nephrotoxicity? Double-blind study and description of a new vascular lesion in kidneys. Antimicrob Agents Chemother. 1976 Sep;10(3):555–563. doi: 10.1128/aac.10.3.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. CIRKSENA W. J., BASTIAN R. C., MALLOY J. P., BARRY K. G. USE OF MANNITOL IN EXOGENOUS AND ENDOGENOUS INTOXICATIONS. N Engl J Med. 1964 Jan 23;270:161–166. doi: 10.1056/NEJM196401232700401. [DOI] [PubMed] [Google Scholar]
  16. Christodoulou J., Erlandson R., Smithen C., Killip T., Brachfeld N. Effects of mannitol on cardiac ultrastructure and microcirculation following anoxia. Am J Physiol. 1975 Sep;229(3):853–860. doi: 10.1152/ajplegacy.1975.229.3.853. [DOI] [PubMed] [Google Scholar]
  17. Cottrell J. E., Robustelli A., Post K., Turndorf H. Furosemide- and mannitol-induced changes in intracranial pressure and serum osmolality and electrolytes. Anesthesiology. 1977 Jul;47(1):28–30. doi: 10.1097/00000542-197707000-00006. [DOI] [PubMed] [Google Scholar]
  18. Cvitkovic E., Spaulding J., Bethune V., Martin J., Whitmore W. F. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer. 1977 Apr;39(4):1357–1361. doi: 10.1002/1097-0142(197704)39:4<1357::aid-cncr2820390402>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  19. DAWSON J. L. JAUNDICE AND ANOXIC RENAL DAMAGE: PROTECTIVE EFFECT OF MANNITOL. Br Med J. 1964 Mar 28;1(5386):810–811. doi: 10.1136/bmj.1.5386.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. DAWSON J. L. POST-OPERATIVE RENAL FUNCTION IN OBSTRUCTIVE JAUNDICE: EFFECT OF A MANNITOL DIURESIS. Br Med J. 1965 Jan 9;1(5427):82–86. doi: 10.1136/bmj.1.5427.82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. DOBERNECK R. C., SCHWARTZ F. D., BARRY K. G. A comparison of the prophylactic value of 20 per cent dextrose on the effects of renal ischemia. J Urol. 1963 Mar;89:300–302. doi: 10.1016/S0022-5347(17)64547-6. [DOI] [PubMed] [Google Scholar]
  22. Danielson B. G., Grängsjö G., Karkmark B., Wolgast M. Kidney function and intrarenal blood flow distribution after bleeding and infusions of mannitol and dextran. Acta Anaesthesiol Scand. 1973;17(1):8–21. doi: 10.1111/j.1399-6576.1973.tb00790.x. [DOI] [PubMed] [Google Scholar]
  23. Deshmukh M. A., Shah S., Shah S., Joglekar S. J. Extra-amniotic mannitol for pregnancy termination (preliminary report). J Postgrad Med. 1976 Jan;22(1):23–25. [PubMed] [Google Scholar]
  24. Detmer D. E., Zimmerman J. M., King T. C. Mannitol diuresis: the relationship of plasma volume to renal blood flow. J Surg Res. 1965 Dec;5(12):552–555. doi: 10.1016/s0022-4804(65)80041-5. [DOI] [PubMed] [Google Scholar]
  25. DiScala V. A., Mautner W., Cohen J. A., Levitt M. F., Churg J., Yunis S. L. Tubular alterations produced by osmotic diuresis with mannitol. Ann Intern Med. 1965 Nov;63(5):767–775. doi: 10.7326/0003-4819-63-5-767. [DOI] [PubMed] [Google Scholar]
  26. ELIAHOU H. E. MANNITOL THERAPY IN OLIGURIA OF ACUTE ONSET. Br Med J. 1964 Mar 28;1(5386):807–809. doi: 10.1136/bmj.1.5386.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. ETHEREDGE E. E., LEVITIN H., NAKAMURA K., GLENN W. W. EFFECT OF MANNITOL ON RENAL FUNCTION DURING OPEN-HEART SURGERY. Ann Surg. 1965 Jan;161:53–62. doi: 10.1097/00000658-196501000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Flores J., DiBona D. R., Beck C. H., Leaf A. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest. 1972 Jan;51(1):118–126. doi: 10.1172/JCI106781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Franklin W. A., Ganote C. E., Jennings R. B. Blood reflow after renal ischemia. Effects of hypertonic mannitol on reflow and tubular necrosis after transient ischemia in the rat. Arch Pathol. 1974 Aug;98(2):106–111. [PubMed] [Google Scholar]
  30. GOLUBOFF B., SHENKIN H. A., HAFT H. THE EFFECTS OF MANNITOL AND UREA ON CEREBRAL HEMODYNAMICS AND CEREBROSPINAL FLUID PRESSURE. Neurology. 1964 Oct;14:891–898. doi: 10.1212/wnl.14.10.891. [DOI] [PubMed] [Google Scholar]
  31. Gagnon O., Gertman P. M., Iber F. L. Comparison of oral isosorbide and intravenous mannitol as adjuncts to the diuresis of patients with cirrhosis of the liver. Am J Med Sci. 1967 Sep;254(3):284–295. doi: 10.1097/00000441-196709000-00003. [DOI] [PubMed] [Google Scholar]
  32. Gennari F. J., Kassirer J. P. Osmotic diuresis. N Engl J Med. 1974 Oct 3;291(14):714–720. doi: 10.1056/NEJM197410032911408. [DOI] [PubMed] [Google Scholar]
  33. Gjerris F., Schmidt K. Chronic subdural hematoma. Surgery or mannitol treatment. J Neurosurg. 1974 May;40(5):639–642. doi: 10.3171/jns.1974.40.5.0639. [DOI] [PubMed] [Google Scholar]
  34. Gurr F. W. Scroggie JG: Eucalyptus oil poisoning treated by dialysis and mannitol infusion, with an appendix on the analysis of biological fluids for alcohol and eucalyptol. Australas Ann Med. 1965 Aug;14(3):238–249. doi: 10.1111/imj.1965.14.3.238. [DOI] [PubMed] [Google Scholar]
  35. Hagstam K. E., Lindergård B., Tibbling G. Mannitol infusion in regular haemodialysis treatment for chronic renal insufficiency. Scand J Urol Nephrol. 1969;3(3):257–263. doi: 10.3109/00365596909135413. [DOI] [PubMed] [Google Scholar]
  36. Hamburger J. I., Desai P. Mannitol augmentation of I-131 uptake in the treatment of thyroid carcinoma. Metabolism. 1966 Dec;15(12):1055–1058. doi: 10.1016/0026-0495(66)90093-x. [DOI] [PubMed] [Google Scholar]
  37. Hayes D. M., Cvitkovic E., Golbey R. B., Scheiner E., Helson L., Krakoff I. H. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer. 1977 Apr;39(4):1372–1381. doi: 10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  38. Hoff H. E., Deavers S., Huggins R. A. Effect of hypertonic glucose and mannitol on plasma volume. Proc Soc Exp Biol Med. 1966 Jul;122(3):630–634. doi: 10.3181/00379727-122-31211. [DOI] [PubMed] [Google Scholar]
  39. Hutton I., Curry G. C., Templeton G. H., Willerson J. T. Influence of hypertonic mannitol on regional myocardial blood flow and ventricular performance in awake, intact dogs with prolonged coronary artery occlusion. Cardiovasc Res. 1975 May;9(3):409–419. doi: 10.1093/cvr/9.3.409. [DOI] [PubMed] [Google Scholar]
  40. Janssen C. W., Jr Osmotic nephrosis. A clinical and experimental investigation. Acta Chir Scand. 1968;134(6):481–487. [PubMed] [Google Scholar]
  41. KAHN D. R., CERNY J. C., LEE R. W., SLOAN H. THE EFFECT OF DEXTRAN AND MANNITOL ON RENAL FUNCTION DURING OPEN-HEART SURGERY. Surgery. 1965 May;57:676–679. [PubMed] [Google Scholar]
  42. Kindt G. W., Waldman J., Kohl S., Baublis J., Tucker R. P. Intracranial pressure in Reye syndrome. Monitoring and control. JAMA. 1975 Feb 24;231(8):822–825. [PubMed] [Google Scholar]
  43. Kloner R. A., Reimer K. A., Willerson J. T., Jennings R. B. Reduction of experimental myocardial infarct size with hyperosmolar mannitol. Proc Soc Exp Biol Med. 1976 Apr;151(4):677–683. doi: 10.3181/00379727-151-39285. [DOI] [PubMed] [Google Scholar]
  44. Knochel J. P. Hematuria in sickle cell trait: the effect of intravenous administration of distilled water, urinary alkalinization, and diuresis. Arch Intern Med. 1969 Feb;123(2):160–165. doi: 10.1001/archinte.123.2.160. [DOI] [PubMed] [Google Scholar]
  45. Krishnamurty V. S., Adams H. R., Smitherman T. C., Templeton G. H., Willerson J. T. Influence of mannitol on contractile responses of isolated perfused arteries. Am J Physiol. 1977 Jan;232(1):H59–H66. doi: 10.1152/ajpheart.1977.232.1.H59. [DOI] [PubMed] [Google Scholar]
  46. LILIEN O. M., JONES S. G., MUELLER C. B. THE MECHANISM OF MANNITOL DIURESIS. Surg Gynecol Obstet. 1963 Aug;117:221–228. [PubMed] [Google Scholar]
  47. Lazar M., Nowakowski J., Furman M., Shore B. Ocular penetration of topically applied mannitol. Am J Ophthalmol. 1970 Nov;70(5):849–851. doi: 10.1016/0002-9394(70)90511-8. [DOI] [PubMed] [Google Scholar]
  48. Lilien C. M. The paradoxical reaction of renal vasculature to mannitol. Invest Urol. 1973 Mar;10(5):346–353. [PubMed] [Google Scholar]
  49. MacCuish A. C., Munro J. F., Duncan L. J. Treatment of hypoglycaemic coma with glucagon, intravenous dextrose, and mannitol infusion in a hundred diabetics. Lancet. 1970 Nov 7;2(7680):946–949. doi: 10.1016/s0140-6736(70)92126-4. [DOI] [PubMed] [Google Scholar]
  50. Maesaka J. K., Berger M. L., Bornia M. E., Abramson R. G., Levitt M. F. Effect of mannitol on phosphate transport in intact and acutely thyroparathyroidectomized rats. J Lab Clin Med. 1976 Apr;87(4):680–691. [PubMed] [Google Scholar]
  51. Moreno M., Murphy C., Goldsmith C. Increase in serum potassium resulting from the administration of hypertonic mannitol and other solutions. J Lab Clin Med. 1969 Feb;73(2):291–298. [PubMed] [Google Scholar]
  52. Oetliker O. H., Simon J., Tietze H. U. Diagnostic value of mannitol-induced diuresis in children. Acta Paediatr Scand. 1974 Jan;63(1):113–121. doi: 10.1111/j.1651-2227.1974.tb04358.x. [DOI] [PubMed] [Google Scholar]
  53. Oldendorf W. H., Kitano M. The early disappearance of extracellular tracers from plasma after intravenous injection. Proc Soc Exp Biol Med. 1972 Dec;141(3):940–943. doi: 10.3181/00379727-141-36906. [DOI] [PubMed] [Google Scholar]
  54. Olivero J. J., Lozano-Mendez J., Ghafary E. M., Eknoyan G., Suki W. N. Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J. 1975 Mar 8;1(5957):550–551. doi: 10.1136/bmj.1.5957.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. POWERS S. R., Jr, BOBA A., HOSTNIK W., STEIN A. PREVENTION OF POSTOPERATIVE ACUTE RENAL FAILURE WITH MANNITOL IN 100 CASES. Surgery. 1964 Jan;55:15–23. [PubMed] [Google Scholar]
  56. Parfitt A. M. The acute effects of mersalyl, chlorothiazide and mannitol on the renal excretion of calcium and other ions in man. Clin Sci. 1969 Apr;36(2):267–282. [PubMed] [Google Scholar]
  57. Parker A. J., Park R. D., Stowater J. L. Reduction of trauma-induced edema of spinal cord in dogs given mannitol. Am J Vet Res. 1973 Oct;34(10):1355–1357. [PubMed] [Google Scholar]
  58. Polec R. B., Yeh S. D., Shils M. E. Protective effect of ascorbic acid, isoascorbic acid and mannitol against tetracycline-induced nephrotoxicity. J Pharmacol Exp Ther. 1971 Jul;178(1):152–158. [PubMed] [Google Scholar]
  59. Powell W. J., Jr, DiBona D. R., Flores J., Leaf A. The protective effect of hyperosmotic mannitol in myocardial ischemia and necrosis. Circulation. 1976 Oct;54(4):603–615. doi: 10.1161/01.cir.54.4.603. [DOI] [PubMed] [Google Scholar]
  60. Powers S. R., Jr, Shah D., Ryon D., Newell J., Ralph C., Scovill W., Dutton R. Hypertonic mannitol in the therapy of the acute respiratory distress syndrome. Ann Surg. 1977 Jun;185(6):619–625. doi: 10.1097/00000658-197706000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Prowse K., Pain M., Marston A. D., Cumming G. The treatment of salicylate poisoning using mannitol and forced alkaline diuresis. Clin Sci. 1970 Mar;38(3):327–337. doi: 10.1042/cs0380327. [DOI] [PubMed] [Google Scholar]
  62. Raizner A. E., Costin J. C., Croke R. P., Bishop J. B., Inglesby T. V., Skinner N. S., Jr Reflex, systemic, and local hemodynamic alterations with experimental hyperosmolality. Am J Physiol. 1973 Jun;224(6):1327–1333. doi: 10.1152/ajplegacy.1973.224.6.1327. [DOI] [PubMed] [Google Scholar]
  63. Richardson H. D., Nakamaura S. An electron microscopic study of spinal cord edema and the effect of treatment with steroids, mannitol, and hypothermia. Proc Veterans Adm Spinal Cord Inj Conf. 1971;18:10–16. [PubMed] [Google Scholar]
  64. Rodrigo F., Shideman J., McHugh R., Buselmeier T., Kjellstrand C. Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol. Ann Intern Med. 1977 May;86(5):554–561. doi: 10.7326/0003-4819-86-5-554. [DOI] [PubMed] [Google Scholar]
  65. Rosch J. M., Pazin G. J., Fireman P. Reduction of amphotericin B nephrotoxicity with mannitol. JAMA. 1976 May 3;235(18):1995–1996. [PubMed] [Google Scholar]
  66. SHENKIN H. A., GOLUBOFF B., HAFT H. The use of mannitol for the reduction of intracranial pressure in intracranial surgery. J Neurosurg. 1962 Oct;19:897–901. doi: 10.3171/jns.1962.19.10.0897. [DOI] [PubMed] [Google Scholar]
  67. Schroder K., Gessler U. The influence of mannitol, ethacrynic acid and frusemide on glomerular filtration in experimental acute renal failure. Postgrad Med J. 1971 Apr;47(Suppl):11–12. [PubMed] [Google Scholar]
  68. Seely J. F., Dirks J. H. Micropuncture study of hypertonic mannitol diuresis in the proximal and distal tubule of the dog kidney. J Clin Invest. 1969 Dec;48(12):2330–2340. doi: 10.1172/JCI106199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Shalit M. N. Effect of intracarotid artery administration of mannitol on cerebral blood flow and intracranial pressure in experimental brain edema. Isr J Med Sci. 1974 Jun;10(6):577–580. [PubMed] [Google Scholar]
  70. Shenkin H. A., Goluboff B., Haft H. Further observations on the effects of abruptly increased osmotic pressure of plasma on cerebrosinal-fluid pressure in man. J Neurosurg. 1965 Jun;22(6):563–568. doi: 10.3171/jns.1965.22.6.0563. [DOI] [PubMed] [Google Scholar]
  71. Silber S. J., Thompson N. Mannitol induced central nervous system toxicity in renal failure. Invest Urol. 1972 Jan;9(4):310–312. [PubMed] [Google Scholar]
  72. Skeith M. D., Healey L. A., Cutler R. E. Urate excretion during mannitol and glucose diuresis. J Lab Clin Med. 1967 Aug;70(2):213–220. [PubMed] [Google Scholar]
  73. Smithen C., Christodoulou J., Killip T., Brachfeld N. Metabolic and hemodynamic consequences of mannitol following myocardial anoxia. Am J Physiol. 1975 Sep;229(3):847–852. doi: 10.1152/ajplegacy.1975.229.3.847. [DOI] [PubMed] [Google Scholar]
  74. Sotorník I., Schück O., Stríbrná J. Influence of diuretics on renal calcium excretion. Experientia. 1969 Jun 15;25(6):591–592. doi: 10.1007/BF01896529. [DOI] [PubMed] [Google Scholar]
  75. Spaeth G. L., Spaeth E. B., Spaeth P. G., Lucier A. C. Anaphylactic reaction to mannitol. Arch Ophthalmol. 1967 Nov;78(5):583–584. doi: 10.1001/archopht.1967.00980030585004. [DOI] [PubMed] [Google Scholar]
  76. Suzuki J., Takaku A. Nonsurgical treatment of chronic subdural hematoma. J Neurosurg. 1970 Nov;33(5):548–553. doi: 10.3171/jns.1970.33.5.0548. [DOI] [PubMed] [Google Scholar]
  77. Szabó G., Magyar S. Effect of hypertonic mannitol solution on circulation and renal function in acute blood loss. Acta Med Acad Sci Hung. 1967;23(4):325–335. [PubMed] [Google Scholar]
  78. TAYLOR R. D., BIRCHALL R., PAGE I. H. Monocytic leukemia, an uncommon cause of renal failure. Ann Intern Med. 1950 Jun;32(6):1197–1202. doi: 10.7326/0003-4819-32-6-1197. [DOI] [PubMed] [Google Scholar]
  79. Takimoto N., Watanabe M., Kinjo T., Hori M., Kuroda R. [Clinical study on penetration of antibiotics into cerebrospinal fluid (second report),-Study on intravenous administration of sodium cephalothin with mannitol solution (author's transl)]. No Shinkei Geka. 1977 Feb;5(2):137–143. [PubMed] [Google Scholar]
  80. Taylor D. A., Chovnick S. D., Phillips S. H. The use of rapid sequence mannitol pyelography in the diagnosis of renovascular hypertension. Radiology. 1967 Dec;89(6):1095–1099. doi: 10.1148/89.6.1095. [DOI] [PubMed] [Google Scholar]
  81. Taylor D. A., Macken K. L., Fiore A. S. Mannitol pyelography: a simplification of the drip infusion technic. Radiology. 1967 Jun;88(6):1117–1120. doi: 10.1148/88.6.1117. [DOI] [PubMed] [Google Scholar]
  82. Temes S. P., Lilien O. M., Chamberlain W. A direct vasoconstrictor effect of mannitol on the renal artery. Surg Gynecol Obstet. 1975 Aug;141(2):223–226. [PubMed] [Google Scholar]
  83. Tunner W. S., Kiser W. S., Mann P. Studies on the significance of decreased serum sodium levels following the clinical use of mannitol. J Urol. 1965 Oct;94(4):470–474. doi: 10.1016/S0022-5347(17)63651-6. [DOI] [PubMed] [Google Scholar]
  84. Velasquez M. T., Notargiacomo A. V., Cohn J. N. Comparative effects of saline and mannitol on renal cortical blood flow and volume in the dog. Am J Physiol. 1973 Feb;224(2):322–327. doi: 10.1152/ajplegacy.1973.224.2.322. [DOI] [PubMed] [Google Scholar]
  85. WISE B. L., CHATER N. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure. J Neurosurg. 1962 Dec;19:1038–1043. doi: 10.3171/jns.1962.19.12.1038. [DOI] [PubMed] [Google Scholar]
  86. Willerson J. T., Curry G. C., Atkins J. M., Parkey R., Horwitz L. D. Influence of hypertonic mannitol on ventricular performance and coronary blood flow in patients. Circulation. 1975 Jun;51(6):1095–1100. doi: 10.1161/01.cir.51.6.1095. [DOI] [PubMed] [Google Scholar]
  87. Wilson D. R., Thiel G., Arce M. L., Oken D. E. Glycerol induced hemoglobinuric acute renal failure in the rat. 3. Micropuncture study of the effects of mannitol and isotonic saline on individual nephron function. Nephron. 1967;4(6):337–355. doi: 10.1159/000179594. [DOI] [PubMed] [Google Scholar]
  88. Zayed A., Fouad A. R. The role of mannitol osmotherapy in retinal detachment surgery. Bull Ophthalmol Soc Egypt. 1971;64(68):483–490. [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES